BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 31789401)

  • 1. ACSL4 suppresses glioma cells proliferation via activating ferroptosis.
    Cheng J; Fan YQ; Liu BH; Zhou H; Wang JM; Chen QX
    Oncol Rep; 2020 Jan; 43(1):147-158. PubMed ID: 31789401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4.
    Bao C; Zhang J; Xian SY; Chen F
    Free Radic Res; 2021 Jul; 55(7):853-864. PubMed ID: 34323631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ACSL4 as a biomarker and contributor of ferroptosis.
    Yuan H; Li X; Zhang X; Kang R; Tang D
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1338-43. PubMed ID: 27565726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma.
    Zhang Y; Li S; Li F; Lv C; Yang QK
    Biol Direct; 2021 May; 16(1):10. PubMed ID: 34053456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
    Xu Y; Li X; Cheng Y; Yang M; Wang R
    FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsp90 induces Acsl4-dependent glioma ferroptosis via dephosphorylating Ser637 at Drp1.
    Miao Z; Tian W; Ye Y; Gu W; Bao Z; Xu L; Sun G; Li C; Tu Y; Chao H; Lam SM; Liu N; Ji J
    Cell Death Dis; 2022 Jun; 13(6):548. PubMed ID: 35697672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACSL4: a double-edged sword target in multiple myeloma, promotes cell proliferation and sensitizes cell to ferroptosis.
    Zhang J; Liu Y; Li Q; Zuo L; Zhang B; Zhao F; Fan F; Luo S; Hu Y; Sun C
    Carcinogenesis; 2023 May; 44(3):242-251. PubMed ID: 36999754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
    Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X
    Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway.
    Xiaofei J; Mingqing S; Miao S; Yizhen Y; Shuang Z; Qinhua X; Kai Z
    Biochem Biophys Res Commun; 2021 Mar; 545():81-88. PubMed ID: 33548628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.
    Doll S; Proneth B; Tyurina YY; Panzilius E; Kobayashi S; Ingold I; Irmler M; Beckers J; Aichler M; Walch A; Prokisch H; Trümbach D; Mao G; Qu F; Bayir H; Füllekrug J; Scheel CH; Wurst W; Schick JA; Kagan VE; Angeli JP; Conrad M
    Nat Chem Biol; 2017 Jan; 13(1):91-98. PubMed ID: 27842070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACSL4 contributes to ferroptosis-mediated rhabdomyolysis in exertional heat stroke.
    He S; Li R; Peng Y; Wang Z; Huang J; Meng H; Min J; Wang F; Ma Q
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1717-1730. PubMed ID: 35243801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating fat mass and obesity-associated-N6-methyladenosine-acyl-CoA synthetase long-chain family member 4 axis.
    Jin Z; Gao W; Guo F; Liao S; Hu M; Yu T; Yu S; Shi Q
    J Neurochem; 2023 Jul; 166(2):328-345. PubMed ID: 37300304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries.
    Jia B; Li J; Song Y; Luo C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis.
    Xiao FJ; Zhang D; Wu Y; Jia QH; Zhang L; Li YX; Yang YF; Wang H; Wu CT; Wang LS
    Biochem Biophys Res Commun; 2019 Jul; 515(3):448-454. PubMed ID: 31160087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma.
    Feng J; Lu PZ; Zhu GZ; Hooi SC; Wu Y; Huang XW; Dai HQ; Chen PH; Li ZJ; Su WJ; Han CY; Ye XP; Peng T; Zhou J; Lu GD
    Acta Pharmacol Sin; 2021 Jan; 42(1):160-170. PubMed ID: 32541921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis.
    Marteau R; Ravez S; Mazhari Dorooee D; Bouchaoui H; Porte K; Devedjian JC; Melnyk P; Devos D; Frédérick R; El Bakali J
    Biochem Pharmacol; 2022 Oct; 204():115239. PubMed ID: 36075462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsaicin induces redox imbalance and ferroptosis through ACSL4/GPx4 signaling pathways in U87-MG and U251 glioblastoma cells.
    Hacioglu C; Kar F
    Metab Brain Dis; 2023 Feb; 38(2):393-408. PubMed ID: 35438378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.
    Ye X; Zhang Y; Wang X; Li Y; Gao Y
    IUBMB Life; 2016 Apr; 68(4):320-7. PubMed ID: 26949059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of long-chain acyl-CoA synthetase 4 facilitates production of 5, 11-dihydroxyeicosatetraenoic acid via the cyclooxygenase-2 pathway.
    Kuwata H; Hara S
    Biochem Biophys Res Commun; 2015 Sep; 465(3):528-33. PubMed ID: 26282205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACSL4 exacerbates ischemic stroke by promoting ferroptosis-induced brain injury and neuroinflammation.
    Cui Y; Zhang Y; Zhao X; Shao L; Liu G; Sun C; Xu R; Zhang Z
    Brain Behav Immun; 2021 Mar; 93():312-321. PubMed ID: 33444733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.